Towards novel cancer (immuno)therapy using TRAIL and Galectin-9

Thijssen, V. (Examiner)

Activity: Examination

Period10 May 2017
Examinee
Examination held atUniversity Medical Centre Groningen, Groningen, Netherlands
Degree of RecognitionNational